Effects of mifepristone on the proliferation, apoptosis and cis-diamminedichloroplatinum sensitivity of cultured chemoresistant human ovarian cancer cells
Wang, G.; Shang, H-ling.; Xie, Y.; Xiao, P.; Li, X-jie.; Lin, T-cheng.; Li, G-yi.
Chinese Medical Journal 118(4): 333-336
2005
ISSN/ISBN: 0366-6999 PMID: 15740674 Document Number: 590465
Of late, more and more studies are being carried out to explore the anti-tumour activity of mifepristone. As Rose and Barnea1 reported, mifepristone can inhibit the growth of cultured ovarian carcinoma cells. The role of mifepristone in cis-diamminedichloroplatinum (CDDP) and taxol resistant ovarian carcinoma was found in Rocereto and colleagues' study.2 The purpose of this study was to examine the effect of mifepristone on the growth and CDDP-sensitivity of CDDP-resistant human ovarian carcinoma cells and give an experimental basis for the treatment with mifepristone of refractory ovarian carcinoma.